The risk of malnutrition in children with autism spectrum disorder

Author(s):  
Lydia Iris Healy ◽  
Eimear Forbes ◽  
Jane Rice ◽  
Jane M Leonard ◽  
Ellen Crushell

A 9-year-old boy presented with a 2-day history of vomiting, ataxia and reduced consciousness. He had vomited intermittently in the two preceding months, without headaches, visual disturbance or early morning symptoms. He had autism spectrum disorder, and restricted eating since aged 2 years, eating only corn-crisps, Rich Tea biscuits and chips (French fries), and drinking Coca-Cola (containing 10% glucose; figure 1). Recently a dietician had prescribed a multivitamin.Figure 1The patient's complete daily food intake over approximately 7 years (2-3 biscuits per day).Dietary analysis revealed an extremely low protein (0.37 g/kg/day) and low fat (0.77 g/kg/day) diet for over 7 years with a caloric intake of 1200 kCal. Estimated requirements were 1512 kCal,1 0.92 mg/kg/day of protein2 and 1.94 mg/kg of fat (based on 35% of daily calorie intake3).On examination he was encephalopathic, with hepatomegaly and ascites. His height and weight were on the 0.4th–2nd and 9th centiles, respectively. Laboratory results demonstrated glucose 2.7 mmol/L, mild anaemia, raised urea (10.7 mmol/L) with normal creatinine and raised hepatic transaminases, low albumin and elevated creatinine kinase (peak 7809 IU/L). He remained encephalopathic and was intubated for poor respiratory function. Ammonia and blood pH were normal.Question 1What nutritional/metabolic test(s) would be the next best step?Vitamin B1 (thiamine) levelsCopper and caeruloplasmin levelsBlood spot for acylcarnitine profilePlasma amino acid profileUrine organic acidsQuestion 2What potentially dangerous feeding issues in paediatric intensive care exist here?Electrolyte levels and supplementationFat composition of feedsAmino acid composition of feedsVitamin levelsQuestion 3Why might this patient have had preserved vitamin E levels?Vitamin E is added to rancherosSome vitamin E is obtained from sunlightFrench fries are relatively high in vitamin EMultivitamin preparationsQuestion 4What metabolic disorders are associated with very low carnitine levels?Organic acidaemiasFatty acid oxidation disordersMitochondrial disorders (disorders of respiratory chain)Maple syrup urine disease (MSUD)Answers can be found on page 01

2019 ◽  
Vol 20 (8) ◽  
pp. 1878 ◽  
Author(s):  
Rita Barone ◽  
Renata Rizzo ◽  
Giovanni Tabbì ◽  
Michele Malaguarnera ◽  
Richard E. Frye ◽  
...  

Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by defective social communication and interaction and restricted, repetitive behavior with a complex, multifactorial etiology. Despite an increasing worldwide prevalence of ASD, there is currently no pharmacological cure to treat core symptoms of ASD. Clinical evidence and molecular data support the role of impaired mitochondrial fatty acid oxidation (FAO) in ASD. The recognition of defects in energy metabolism in ASD may be important for better understanding ASD and developing therapeutic intervention. The nuclear peroxisome proliferator-activated receptors (PPAR) α, δ, and γ are ligand-activated receptors with distinct physiological functions in regulating lipid and glucose metabolism, as well as inflammatory response. PPAR activation allows a coordinated up-regulation of numerous FAO enzymes, resulting in significant PPAR-driven increases in mitochondrial FAO flux. Resveratrol (RSV) is a polyphenolic compound which exhibits metabolic, antioxidant, and anti-inflammatory properties, pointing to possible applications in ASD therapeutics. In this study, we review the evidence for the existing links between ASD and impaired mitochondrial FAO and review the potential implications for regulation of mitochondrial FAO in ASD by PPAR activators, including RSV.


2020 ◽  
Vol 77 ◽  
pp. 101605
Author(s):  
Anatoly V. Skalny ◽  
Andrey A. Skalny ◽  
Yulia N. Lobanova ◽  
Tatiana V. Korobeinikova ◽  
Olga P. Ajsuvakova ◽  
...  

2019 ◽  
Vol 8 (1) ◽  
Author(s):  
Lauren Cascio ◽  
Chin‐Fu Chen ◽  
Rini Pauly ◽  
Sujata Srikanth ◽  
Kelly Jones ◽  
...  

2020 ◽  
Vol 38 (4) ◽  
pp. 992-1000
Author(s):  
Mingyang Zou ◽  
Dexin Li ◽  
Luxi Wang ◽  
Ling Li ◽  
Shu Xie ◽  
...  

Biochimie ◽  
2021 ◽  
Author(s):  
Neluwa-Liyanage R. Indika ◽  
Nicolaas E.P. Deutz ◽  
Marielle P.K.J. Engelen ◽  
Hemantha Peiris ◽  
Swarna Wijetunge ◽  
...  

Author(s):  
Jean-Baptiste Delaye ◽  
Franck Patin ◽  
Emmanuelle Lagrue ◽  
Olivier Le Tilly ◽  
Clement Bruno ◽  
...  

Objectives Autism spectrum disorders and intellectual disability present a challenge for therapeutic and dietary management. We performed a re-analysis of plasma amino acid chromatography of children with autism spectrum disorders ( n = 22) or intellectual disability ( n = 29) to search for a metabolic signature that can distinguish individuals with these disorders from controls ( n = 30). Methods We performed univariate and multivariate analyses using different machine learning strategies, from the raw data of the amino acid chromatography. Finally, we analysed the metabolic pathways associated with discriminant biomarkers. Results Multivariate analysis revealed models to discriminate patients with autism spectrum disorders or intellectual disability and controls from plasma amino acid profiles ( P < 0.0003). Univariate analysis showed that autism spectrum disorder and intellectual disability patients shared similar differences relative to controls, including lower glutamate ( P < 0.0001 and P = 0.0002, respectively) and serine ( P = 0.002 for both) concentrations. The multivariate model ( P < 6.12.10−7) to discriminate between autism spectrum disorders and intellectual disability revealed the involvement of urea, 3-methyl-histidine and histidine metabolism. Biosigner analysis and univariate analysis confirmed the role of 3-methylhistidine ( P = 0.004), histidine ( P = 0.003), urea ( P = 0.0006) and lysine ( P = 0.002). Conclusions We revealed discriminant metabolic patterns between autism spectrum disorders, intellectual disability and controls. Amino acids known to play a role in neurotransmission were discriminant in the models comparing autism spectrum disorders or intellectual disability to controls, and histidine and b-alanine metabolism was specifically highlighted in the model.


Cell ◽  
2016 ◽  
Vol 167 (6) ◽  
pp. 1481-1494.e18 ◽  
Author(s):  
Dora C. Tărlungeanu ◽  
Elena Deliu ◽  
Christoph P. Dotter ◽  
Majdi Kara ◽  
Philipp Christoph Janiesch ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document